Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes
By: Manuel Reyes and Michael J. Reardon
References
-
Ross
J
Jr , Braunwald E. Aortic stenosis. Circulation. 1968 Jul; 38 1 Suppl: 61– 7. - Nishimura RA , Otto CM , Bonow RO , . ;American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10; 63 22: e57– 185.
- Vahanian A , Alfieri O , Andreotti F , [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome). 2013 Mar; 14 3: 167– 214.
-
Bach
DS
,
Siao
D
,
Girard
SE
,
Duvernoy
C
,
McCallister
BD
Jr , Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009 Nov; 2 6: 533– 9. - Cribier A , Eltchaninoff H , Bash A , Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10; 106 24: 3006– 8.
- Otto CM , Pearlman AS , Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol. 1989 Mar 1; 13 3: 545– 50.
- Leon MB , Smith CR , Mack M , .; PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21. 363 17: 1597– 607.
- Kapadia SR , Tuzcu EM , Makkar RR , Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation. 2014 Oct 21; 130 17: 1483– 92.
- Popma JJ , Adams DH , Reardon MJ , .; CoreValve United States Clinical Investigators Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20; 63 19: 1972– 81.
- Yakubov SJ , Adams DH , Watson DR , .; CoreValve United States Clinical Investigators 2-Year outcomes after iliofemoral self-expanding transcatheter aortic valve replacement in patients with severe aortic stenosis deemed extreme risk for surgery. J Am Coll Cardiol. 2015 Sep 22; 66 12: 1327– 34.
- Smith CR , Leon MB , Mack MJ , .; PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9; 364 23: 2187– 98.
- Mack MJ , Leon MB , Smith CR , .; PARTNER 1 Trial Investigators 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 Jun 20; 385 9986: 2477– 84.
- Adams DH , Popma JJ , Reardon MJ , .; U.S. CoreValve Clinical Investigators Transcatheter aortic-valve replacement with a selfexpanding prosthesis. N Engl J Med. 2014 May 8; 370 19: 1790– 8.
- Reardon MJ , Adams DH , Kleiman NS , 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14; 66 2: 113– 21.
- Deeb GM , Reardon MJ , Chetcuti S , .; CoreValve US Clinical Investigators 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 7; 67 22: 2565– 74.
- Leon MB , Smith CR , Mack MJ , .; PARTNER 2 Investigators Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016 Apr 28; 374 17: 1609– 20.
- Thourani VH , Kodali S , Makkar RR , Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016 May 28; 387 10034: 2218– 25.
- Reardon MJ , Van Mieghem NM , Popma JJ , .; SURTAVI Investigators surgical or transcatheter aortic-valve replacement in intermediate-risk patients. New Engl J Med. 2017 Apr 6; 376 14: 1321– 31.
- Gotzmann M , Korten M , Bojara W , Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2012 Nov 15; 110 10: 1500– 6.
- Gilard M , Eltchaninoff H , Iung B , .; FRANCE 2 Investigators Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012 May 3; 366 18: 1705– 15.
- Willson AB , Webb JG , Labounty TM , 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012 Apr 3; 59 14: 1287– 94.
- Jilaihawi H , Kashif M , Fontana G , Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012 Apr 3; 59 14: 1275– 86.
- Sherif MA , Abdel-Wahab M , Stöcker B , Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010 Nov 9; 56 20: 1623– 9.
- Khalique OK , Hahn RT , Gada H , Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014 Aug; 7 8: 885– 94.
- Ewe SH , Ng AC , Schuijf JD , Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2011 Nov 15; 108 10: 1470– 7.
- Kodali S , Thourani VH , White J , Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016 Jul 21; 37 28: 2252– 62.
- Meredith Am IT , Walters DL , Dumonteil N , Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary end point results from the REPRISE II study. J Am Coll Cardiol. 2014 Sep 30; 64 13: 1339– 48.
-
Leon
MB
;
PARTNER Trial Investigators.
A randomized evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort.
Paper presented at: ACC 2013;
2013 Mar 10 ; San Francisco, CA. -
Linke
A
,
Bosmans
J
,
Gerckens
U.
ADVANCE II: best practices investigation in patients undergoing transcatheter aortic valve implantation with a self-expanding valve.
Paper presented at: EuroPCR 2014;
2014 May 20–23 ; Paris, France. -
Meredith
I.
Pitfalls of TAVI: have they been resolved? Selecting the right patient for TAVI.
Paper presented at: PCR London Valve;
2014 Sep 28–30 ; London, UK. - Khan SS , Trento A , DeRobertis M , Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg. 2001 Aug; 122 2: 257– 69.
- Ruel M , Chan V , Bédard P , Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007 Sep 11; 116 11 Suppl: 1294– 300.
- Chiang YP , Chikwe J , Moskowitz AJ , Itagaki S , Adams DH , Egorova NN , Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA. 2014 Oct 1; 312 13: 1323– 9.
- Jamieson WR , Munro AI , Miyagishima RT , Allen P , Burr LH , Tyers GF. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. Ann Thorac Surg. 1995 Oct; 60 4: 999– 1006; discussion 1007.
- Fann JI , Miller DC , Moore KA , Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg. 1996 Nov; 62 5: 1301– 11; discussion 1311–2.
- Deeb GM , Reardon MJ , Chetcuti S , 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016 Jun 7; 67 22: 2565– 74.
DOI: https://doi.org/10.14797/mdcj-13-3-126 | Journal eISSN: 1947-6108
Language: English
Page range: 126 - 131
Published on: Jul 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2017 Manuel Reyes, Michael J. Reardon, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.